Of worms, mice and man: An overview of experimental and clinical helminth-based therapy for inflammatory bowel disease

Pharmacology and Therapeutics

Volumn 143, Issue 2, 2014, Pages 153-167

  Heylen, Marthe ^a   Ruyssers, Nathalie E ^a   Gielis, Els M ^a   Vanhomwegen, Els ^a   Pelckmans, Paul A ^a,b   Moreels, Tom G ^a,b   De Man, Joris G ^a   De Winter, Benedicte Y ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Colitis; Helminth derived molecules; Helminths; Inflammatory bowel disease; Innate and adaptive immunity; Therapy

Indexed keywords

ADAPTIVE IMMUNITY; ARTICLE; B LYMPHOCYTE; DENDRITIC CELL; ENTERITIS; HELMINTH; HUMAN; IMMUNOMODULATION; INFLAMMATORY BOWEL DISEASE; INNATE IMMUNITY; INTESTINE EPITHELIUM CELL; LYMPHOID CELL; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; THERAPY WITH HELMINTHS; ANIMAL; CLINICAL TRIAL (TOPIC); DISEASE MODEL; IMMUNE SYSTEM DISEASES; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASES; METABOLISM; PROCEDURES;

AUTACOID;

ANIMALS; CLINICAL TRIALS AS TOPIC; DISEASE MODELS, ANIMAL; HUMANS; IMMUNE SYSTEM DISEASES; IMMUNOMODULATION; INFLAMMATION MEDIATORS; INFLAMMATORY BOWEL DISEASES; THERAPY WITH HELMINTHS;

EID: 84902550294     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2014.02.011     Document Type: Review

References (185)

1. K. Abe, K.P. Nguyen, S.D. Fine, J.H. Mo, C. Shen, and S. Shenouda et al. Conventional dendritic cells regulate the outcome of colonic inflammation independently of T cells Proc Natl Acad Sci U S A 104 2007 17022 17027
2. P. Adisakwattana, S. Nuamtanong, T. Kusolsuk, M. Chairoj, P.T. Yenchitsomanas, and U. Chaisri Non-encapsulated Trichinella spp., T. papuae, diminishes severity of DSS-induced colitis in mice Asian Pac J Allergy Immunol 31 2013 106 114
3. J.E. Allen, and R.M. Maizels Diversity and dialogue in immunity to helminths Nat Rev Immunol 11 2011 375 388
4. M. Andersson, A. Boman, and H.G. Boman Ascaris nematodes from pig and human make three antibacterial peptides: isolation of cecropin P1 and two ASABF peptides Cell Mol Life Sci 60 2003 599 606
5. P. Bager, J. Arnved, S. Ronborg, J. Wohlfahrt, L.K. Poulsen, and T. Westergaard et al. Trichuris suis ova therapy for allergic rhinitis: a randomized, double-blind, placebo-controlled clinical trial J Allergy Clin Immunol 125 123-130 2010 e121 e123
6. P. Bager, C. Kapel, A. Roepstorff, S. Thamsborg, J. Arnved, and S. Ronborg et al. Symptoms after ingestion of pig whipworm Trichuris suis eggs in a randomized placebo-controlled double-blind clinical trial PLoS One 6 2011 e22346
7. + dendritic cell subsets in lymph nodes draining the site of intestinal nematode infection Immunol Lett 127 2009 68 75
8. G. Bamias, M.R. Nyce, S.A. De La Rue, and F. Cominelli New concepts in the pathophysiology of inflammatory bowel disease Ann Intern Med 143 2005 895 904
9. L. Bar-On, E. Zigmond, and S. Jung Management of gut inflammation through the manipulation of intestinal dendritic cells and macrophages? Semin Immunol 23 2011 58 64
10. D.C. Baumgart, and S.R. Carding Inflammatory bowel disease: cause and immunobiology Lancet 369 2007 1627 1640
11. D.C. Baumgart, and W.J. Sandborn Crohn's disease Lancet 380 2012 1590 1605
12. D. Ben-Ami Shor, M. Harel, R. Eliakim, and Y. Shoenfeld The hygiene theory harnessing helminths and their ova to treat autoimmunity Clin Rev Allergy Immunol 45 2013 211 216
13. F. Benzel, H. Erdur, S. Kohler, M. Frentsch, A. Thiel, and L. Harms et al. Immune monitoring of Trichuris suis egg therapy in multiple sclerosis patients J Helminthol 86 2012 339 347
14. Y. Bi, G. Liu, and R. Yang Th17 cell induction and immune regulatory effects J Cell Physiol 211 2007 273 278
15. D. Blount, D. Hooi, J. Feary, A. Venn, G. Telford, and A. Brown et al. Immunologic profiles of persons recruited for a randomized, placebo-controlled clinical trial of hookworm infection Am J Trop Med Hyg 81 2009 911 916
16. A.M. Blum, L. Hang, T. Setiawan, J.P. Urban Jr., K.M. Stoyanoff, and J. Leung et al. Heligmosomoides polygyrus bakeri induces tolerogenic dendritic cells that block colitis and prevent antigen-specific gut T cell responses J Immunol 189 2012 2512 2520
17. P. Bodammer, G. Waitz, M. Loebermann, M.C. Holtfreter, C. Maletzki, and M.R. Krueger et al. Schistosoma mansoni infection but not egg antigen promotes recovery from colitis in outbred NMRI mice Dig Dis Sci 56 2011 70 78
18. N.A. Braus, and D.E. Elliott Advances in the pathogenesis and treatment of IBD Clin Immunol 132 2009 1 9
19. M.J. Broadhurst, A. Ardeshir, B. Kanwar, J. Mirpuri, U.M. Gundra, and J.M. Leung et al. Therapeutic helminth infection of macaques with idiopathic chronic diarrhea alters the inflammatory signature and mucosal microbiota of the colon PloS Pathog 8 2012 e1003000
20. + T cells are associated with therapeutic Trichuris trichiura infection in an ulcerative colitis patient Sci Transl Med 2 2010 60 88
21. S. Buonocore, P.P. Ahern, H.H. Uhlig, I.I. Ivanov, D.R. Littman, and K.J. Maloy et al. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology Nature 464 2010 1371 1375
22. M.Z. Cader, and A. Kaser Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation Gut 62 2013 1653 1664
23. G.G. Cancado, J.A. Fiuza, N.C. de Paiva, C. Lemos Lde, N.D. Ricci, and P.H. Gazzinelli-Guimaraes et al. Hookworm products ameliorate dextran sodium sulfate-induced colitis in BALB/c mice Inflamm Bowel Dis 17 2011 2275 2286
24. C. Cantacessi, N.D. Young, P. Nejsum, A.R. Jex, B.E. Campbell, and R.S. Hall et al. The transcriptome of Trichuris suis - first molecular insights into a parasite with curative properties for key immune diseases of humans PLoS One 6 2011 e23590
25. C.C. Chen, S. Louie, B. McCormick, W.A. Walker, and H.N. Shi Concurrent infection with an intestinal helminth parasite impairs host resistance to enteric Citrobacter rodentium and enhances Citrobacter-induced colitis in mice Infect Immun 73 2005 5468 5481
26. C.C. Chen, S. Louie, B.A. McCormick, W.A. Walker, and H.N. Shi Helminth-primed dendritic cells alter the host response to enteric bacterial infection J Immunol 176 2006 472 483
27. M.K. Cho, C.H. Lee, and H.S. Yu Amelioration of intestinal colitis by macrophage migration inhibitory factor isolated from intestinal parasites through toll-like receptor 2 Parasite Immunol 33 2011 265 275
28. A. Cooke, P. Zaccone, T. Raine, J.M. Phillips, and D.W. Dunne Infection and autoimmunity: are we winning the war, only to lose the peace? Trends Parasitol 20 2004 316 321
29. N. Cools, P. Ponsaerts, V.F. Van Tendeloo, and Z.N. Berneman Regulatory T cells and human disease Clin Dev Immunol 2007 2007 89195
30. P.J. Cooper, M.E. Chico, L.C. Rodrigues, M. Ordonez, D. Strachan, and G.E. Griffin et al. Reduced risk of atopy among school-age children infected with geohelminth parasites in a rural area of the tropics J Allergy Clin Immunol 111 2003 995 1000
31. Coronado Biosciences Press Release Coronado Biosciences announce top-line results from its TRUST-I phase 2 clinical trial of TSO for the treatment of Crohn's disease http://ir.coronadobiosciences.com/SearchResults.aspx?iid= 4308955&q=TRUST-I&site=PRs 2013
32. J. Correale, and M. Farez Association between parasite infection and immune responses in multiple sclerosis Ann Neurol 61 2007 97 108
33. J. Correale, and M.F. Farez The impact of parasite infections on the course of multiple sclerosis J Neuroimmunol 233 2011 6 11
34. J. Correale, M. Farez, and G. Razzitte Helminth infections associated with multiple sclerosis induce regulatory B cells Ann Neurol 64 2008 187 199
35. J. Croese, J. O'Neil, J. Masson, S. Cooke, W. Melrose, and D. Pritchard et al. A proof of concept study establishing Necator americanus in Crohn's patients and reservoir donors Gut 55 2006 136 137
36. S.M. Cruickshank, M.L. Deschoolmeester, M. Svensson, G. Howell, A. Bazakou, and L. Logunova et al. Rapid dendritic cell mobilization to the large intestinal epithelium is associated with resistance to Trichuris muris infection J Immunol 182 2009 3055 3062
37. A.J. Daveson, D.M. Jones, S. Gaze, H. McSorley, A. Clouston, and A. Pascoe et al. Effect of hookworm infection on wheat challenge in celiac disease - a randomised double-blinded placebo controlled trial PLoS One 6 2011 e17366
38. G. De Hertogh, J. Aerssens, K.P. Geboes, and K. Geboes Evidence for the involvement of infectious agents in the pathogenesis of Crohn's disease World J Gastroenterol 14 2008 845 852
39. B. De Vroey, and J.F. Colombel IBD in 2010: optimizing treatment and minimizing adverse events Nat Rev Gastroenterol Hepatol 8 2011 74 76
40. T.L. Denning, Y.C. Wang, S.R. Patel, I.R. Williams, and B. Pulendran Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses Nat Immunol 8 2007 1086 1094
41. A. Diaz, and J.E. Allen Mapping immune response profiles: the emerging scenario from helminth immunology Eur J Immunol 37 2007 3319 3326
42. K. Donskow-Lysoniewska, P. Majewski, K. Brodaczewska, K. Jozwicka, and M. Doligalska Heligmosmoides polygyrus fourth stages induce protection against DSS-induced colitis and change opioid expression in the intestine Parasite Immunol 34 2012 536 546
43. G. Dothel, V. Vasina, G. Barbara, and F. De Ponti Animal models of chemically induced intestinal inflammation: predictivity and ethical issues Pharmacol Ther 139 2013 71 86
44. L. Du, H. Tang, Z. Ma, J. Xu, W. Gao, and J. Chen et al. The protective effect of the recombinant 53-kDa protein of Trichinella spiralis on experimental colitis in mice Dig Dis Sci 56 2011 2810 2817
45. D.W. Dunne, and A. Cooke A worm's eye view of the immune system: consequences for evolution of human autoimmune disease Nat Rev Immunol 5 2005 420 426
46. M.B. Dwinell, P. Bass, D.M. Schaefer, and J.A. Oaks Tapeworm infection decreases intestinal transit and enteric aerobic bacterial populations Am J Physiol 273 1997 G480 G485
47. B. Eksteen, L.S. Walker, and D.H. Adams Immune regulation and colitis: suppression of acute inflammation allows the development of chronic inflammatory bowel disease Gut 54 2005 4 6
48. D.E. Elliott, J. Li, A. Blum, A. Metwali, K. Qadir, and J.F. Urban Jr. et al. Exposure to schistosome eggs protects mice from TNBS-induced colitis Am J Physiol Gastrointest Liver Physiol 284 2003 G385 G391
49. D.E. Elliott, A. Metwali, J. Leung, T. Setiawan, A.M. Blum, and M.N. Ince et al. Colonization with Heligmosomoides polygyrus suppresses mucosal IL-17 production J Immunol 181 2008 2414 2419
50. D.E. Elliott, T. Setiawan, A. Metwali, A. Blum, J.F. Urban Jr., and J.V. Weinstock Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice Eur J Immunol 34 2004 2690 2698
51. D.E. Elliott, R.W. Summers, and J.V. Weinstock Helminths and the modulation of mucosal inflammation Curr Opin Gastroenterol 21 2005 51 58
52. D.E. Elliott, R.W. Summers, and J.V. Weinstock Helminths as governors of immune-mediated inflammation Int J Parasitol 37 2007 457 464
53. D.E. Elliott, J.J. Urban, C.K. Argo, and J.V. Weinstock Does the failure to acquire helminthic parasites predispose to Crohn's disease? FASEB J 14 2000 1848 1855
54. D.E. Elliott, and J.V. Weinstock Helminth-host immunological interactions: prevention and control of immune-mediated diseases Ann N Y Acad Sci 1247 2012 83 96
55. D.E. Elliott, and J.V. Weinstock Where are we on worms? Curr Opin Gastroenterol 28 2012 551 556
56. C.O. Elson, Y. Cong, V.J. McCracken, R.A. Dimmitt, R.G. Lorenz, and C.T. Weaver Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota Immunol Rev 206 2005 260 276
57. J. Farache, E. Zigmond, G. Shakhar, and S. Jung Contributions of dendritic cells and macrophages to intestinal homeostasis and immune defense Immunol Cell Biol 91 2013 232 239
58. J.R. Feary, A.J. Venn, K. Mortimer, A.P. Brown, D. Hooi, and F.H. Falcone et al. Experimental hookworm infection: a randomized placebo-controlled trial in asthma Clin Exp Allergy 40 2010 299 306
59. H. Feillet, and J.F. Bach Increased incidence of inflammatory bowel disease: the price of the decline of infectious burden? Curr Opin Gastroenterol 20 2004 560 564
60. + T cell responses and suppress pathology in a mouse model of colitis Infect Immun 81 2013 2104 2111
61. C. Fiocchi Inflammatory bowel disease: etiology and pathogenesis Gastroenterology 115 1998 182 205
62. C. Fiocchi Genes and 'in-vironment': how will our concepts on the pathophysiology of inflammatory bowel disease develop in the future? Dig Dis 30 Suppl. 3 2012 2 11
63. J.O. Fleming Helminths and multiple sclerosis: will old friends give us new treatments for MS? J Neuroimmunol 233 2011 3 5
64. J.O. Fleming Helminth therapy and multiple sclerosis Int J Parasitol 43 2013 259 274
65. J.O. Fleming, A. Isaak, J.E. Lee, C.C. Luzzio, M.D. Carrithers, and T.D. Cook et al. Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study Mult Scler 17 2011 743 754
66. S. Flowers, and M. Hopkins Autoimmune disease: patients self-treat with parasitic worms Nature 493 2013 163
67. M. Fujimoto Regulatory B cells in skin and connective tissue diseases J Dermatol Sci 60 2010 1 7
68. S.K. Garg, A.M. Croft, and P. Bager Helminth therapy (worms) for induction of remission in inflammatory bowel disease Cochrane Database Syst Rev 1 2014 CD009400
69. S. Gordon, and F.O. Martinez Alternative activation of macrophages: mechanism and functions Immunity 32 2010 593 604
70. L.J. Hall, C.T. Murphy, A. Quinlan, G. Hurley, F. Shanahan, and K. Nally et al. Natural killer cells protect mice from DSS-induced colitis by regulating neutrophil function via the NKG2A receptor Mucosal Immunol 6 2013 1016 1026
71. + T cells enhancing their capacity to prevent colitis J Immunol 191 2013 1927 1934
72. L. Hang, T. Setiawan, A.M. Blum, J. Urban, K. Stoyanoff, and S. Arihiro et al. Heligmosomoides polygyrus infection can inhibit colitis through direct interaction with innate immunity J Immunol 185 2010 3184 3189
73. W. Harnett, and M.M. Harnett Immunomodulatory activity and therapeutic potential of the filarial nematode secreted product, ES-62 Adv Exp Med Biol 666 2009 88 94
74. A.L. Hart, H.O. Al-Hassi, R.J. Rigby, S.J. Bell, A.V. Emmanuel, and S.C. Knight et al. Characteristics of intestinal dendritic cells in inflammatory bowel diseases Gastroenterology 129 2005 50 65
75. + T-cell responses to intestinal commensal bacteria Nature 498 2013 113 117
76. J.L. Hernandez, G. Leung, and D.M. McKay Cestode regulation of inflammation and inflammatory diseases Int J Parasitol 43 2013 233 243
77. M. Heylen, N. Ruyssers, J.G. De Man, P. Pelckmans, B. De Winter, and T.G. Moreels The therapeutic potential of helminth proteins in a chronic colitis transfer model Acta Gastroenterol Belg 74 2013 I02
78. M. Heylen, N. Ruyssers, S. Nullens, J.G. De Man, D.M. Schrijvers, and I. Van Brussel et al. Helminth egg antigens and their protective effect on colitis in a murine transfer model Acta Gastroenterol Belg 77 2014 I03
79. M.M. Hunter, and D.M. McKay Review article: helminths as therapeutic agents for inflammatory bowel disease Aliment Pharmacol Ther 19 2004 167 177
80. M.M. Hunter, A. Wang, C.L. Hirota, and D.M. McKay Neutralizing anti-IL-10 antibody blocks the protective effect of tapeworm infection in a murine model of chemically induced colitis J Immunol 174 2005 7368 7375
81. M.M. Hunter, A. Wang, and D.M. McKay Helminth infection enhances disease in a murine TH2 model of colitis Gastroenterology 132 2007 1320 1330
82. M.M. Hunter, A. Wang, K.S. Parhar, M.J. Johnston, N. Van Rooijen, and P.L. Beck et al. In vitro-derived alternatively activated macrophages reduce colonic inflammation in mice Gastroenterology 138 2010 1395 1405
83. M.N. Ince, and D.E. Elliott Immunologic and molecular mechanisms in inflammatory bowel disease Surg Clin N Am 87 2007 681 696
84. M.N. Ince, D.E. Elliott, T. Setiawan, A. Metwali, A. Blum, and H.L. Chen et al. Role of T cell TGF-beta signaling in intestinal cytokine responses and helminthic immune modulation Eur J Immunol 39 2009 1870 1878
85. J.A. Jackson, I.M. Friberg, S. Little, and J.E. Bradley Review series on helminths, immune modulation and the hygiene hypothesis: immunity against helminths and immunological phenomena in modern human populations: coevolutionary legacies? Immunology 126 2009 18 27
86. + macrophage recruitment Korean J Parasitol 49 2011 245 254
87. M.K. Jeon, C. Klaus, E. Kaemmerer, and N. Gassler Intestinal barrier: molecular pathways and modifiers World J Gastrointest Pathophysiol 4 2013 94 99
88. C.J. Johnston, H.J. McSorley, S.M. Anderton, S.J. Wigmore, and R.M. Maizels Helminths and immunological tolerance Transplantation 97 2014 127 132
89. M.J. Johnston, A. Wang, M.E. Catarino, L. Ball, V.C. Phan, and J.A. MacDonald et al. Extracts of the rat tapeworm, Hymenolepis diminuta, suppress macrophage activation in vitro and alleviate chemically induced colitis in mice Infect Immun 78 2010 1364 1375
90. A.R. Jurjus, N.N. Khoury, and J.M. Reimund Animal models of inflammatory bowel disease J Pharmacol Toxicol Methods 50 2004 81 92
91. M. Kawada, A. Arihiro, and E. Mizoguchi Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease World J Gastroenterol 13 2007 5581 5593
92. H. Kayama, and K. Takeda Regulation of intestinal homeostasis by innate and adaptive immunity Int Immunol 24 2012 673 680
93. W.I. Khan, P.A. Blennerhasset, A.K. Varghese, S.K. Chowdhury, P. Omsted, and Y. Deng et al. Intestinal nematode infection ameliorates experimental colitis in mice Infect Immun 70 2002 5931 5937
94. A.R. Khan, and P.G. Fallon Helminth therapies: translating the unknown unknowns to known knowns Int J Parasitol 43 2013 293 299
95. J.Y. Kim, M.K. Cho, S.H. Choi, K.H. Lee, S.C. Ahn, and D.H. Kim et al. Inhibition of dextran sulfate sodium (DSS)-induced intestinal inflammation via enhanced IL-10 and TGF-beta production by galectin-9 homologues isolated from intestinal parasites Mol Biochem Parasitol 174 2010 53 61
96. D. Knights, K.G. Lassen, and R.J. Xavier Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome Gut 62 2013 1505 1510
97. S. Koyasu, and K. Moro Th2-type innate immune responses mediated by natural helper cells Ann N Y Acad Sci 1283 2013 43 49
98. L.E. Laitman, and S. Dahan Taking inflammatory bowel disease up a Notch Immunol Res 54 2012 69 74
99. A. Lapidus The changing epidemiology of inflammatory bowel diseases Acta Gastroenterol Belg 64 2001 155 159
100. J. Leung, L. Hang, A. Blum, T. Setiawan, K. Stoyanoff, and J. Weinstock Heligmosomoides polygyrus abrogates antigen-specific gut injury in a murine model of inflammatory bowel disease Inflamm Bowel Dis 18 2012 1447 1455
101. S.E. Levison, J.T. McLaughlin, L.A. Zeef, P. Fisher, R.K. Grencis, and J.L. Pennock Colonic transcriptional profiling in resistance and susceptibility to trichuriasis: phenotyping a chronic colitis and lessons for iatrogenic helminthosis Inflamm Bowel Dis 16 2010 2065 2079
102. T.T. MacDonald, I. Monteleone, M.C. Fantini, and G. Monteleone Regulation of homeostasis and inflammation in the intestine Gastroenterology 140 2011 1768 1775
103. E. Magen, G. Borkow, Z. Bentwich, J. Mishal, and S. Scharf Can worms defend our hearts? Chronic helminthic infections may attenuate the development of cardiovascular diseases Med Hypotheses 64 2005 904 909
104. R.M. Maizels, A. Balic, N. Gomez-Escobar, M. Nair, M.D. Taylor, and J.E. Allen Helminth parasites - masters of regulation Immunol Rev 201 2004 89 116
105. R.M. Maizels, J.P. Hewitson, and K.A. Smith Susceptibility and immunity to helminth parasites Curr Opin Immunol 24 2012 459 466
106. E.R. Mann, J.D. Landy, D. Bernardo, S.T. Peake, A.L. Hart, and H.O. Al-Hassi et al. Intestinal dendritic cells: their role in intestinal inflammation, manipulation by the gut microbiota and differences between mice and men Immunol Lett 150 2013 30 40
107. M.A. McGuckin, R. Eri, L.A. Simms, T.H. Florin, and G. Radford-Smith Intestinal barrier dysfunction in inflammatory bowel diseases Inflamm Bowel Dis 15 2009 100 113
108. P. McGuirk, and K.H. Mills Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectious diseases Trends Immunol 23 2002 450 455
109. D.M. McKay, and J.L. Wallace Acetic acid induced ulceration in rats is not affected by infection with Hymenolepis diminuta J Parasitol 95 2009 481 482
110. H.J. McSorley, S. Gaze, J. Daveson, D. Jones, R.P. Anderson, and A. Clouston et al. Suppression of inflammatory immune responses in celiac disease by experimental hookworm infection PLoS One 6 2011 e24092
111. H.J. McSorley, J.P. Hewitson, and R.M. Maizels Immunomodulation by helminth parasites: defining mechanisms and mediators Int J Parasitol 43 2013 301 310
112. H.J. McSorley, and A. Loukas The immunology of human hookworm infections Parasite Immunol 32 2010 549 559
113. H.J. McSorley, and R.M. Maizels Helminth infections and host immune regulation Clin Microbiol Rev 25 2012 585 608
114. R. Medzhitov, and C. Janeway Jr. Innate immunity N Engl J Med 343 2000 338 344
115. E.N. Meeusen Immunology of helminth infections, with special reference to immunopathology Vet Parasitol 84 1999 259 273
116. A. Melon, A. Wang, V. Phan, and D.M. McKay Infection with Hymenolepis diminuta is more effective than daily corticosteroids in blocking chemically induced colitis in mice J Biomed Biotechnol 2010 2010 384 523
117. + regulatory T cells in the intestine by Heligmosomoides polygyrus infection Am J Physiol Gastrointest Liver Physiol 291 2006 G253 G259
118. A. Mizoguchi, and E. Mizoguchi Inflammatory bowel disease, past, present and future: lessons from animal models J Gastroenterol 43 2008 1 17
119. T.G. Moreels, R.J. Nieuwendijk, J.G. De Man, B.Y. De Winter, A.G. Herman, and E.A. Van Marck et al. Concurrent infection with Schistosoma mansoni attenuates inflammation induced changes in colonic morphology, cytokine levels, and smooth muscle contractility of trinitrobenzene sulphonic acid induced colitis in rats Gut 53 2004 99 107
120. T.G. Moreels, and P.A. Pelckmans Gastrointestinal parasites: potential therapy for refractory inflammatory bowel diseases Inflamm Bowel Dis 11 2005 178 184
121. G. Morrison, B. Headon, and P. Gibson Update in inflammatory bowel disease Aust Fam Physician 38 2009 956 961
122. A. Mortha, and A. Diefenbach Natural killer cell receptor-expressing innate lymphocytes: more than just NK cells Cell Mol Life Sci 68 2011 3541 3555
123. Y. Motomura, H. Wang, Y. Deng, R.T. El-Sharkawy, E.F. Verdu, and W.I. Khan Helminth antigen-based strategy to ameliorate inflammation in an experimental model of colitis Clin Exp Immunol 155 2009 88 95
124. A.M. Mowat, and C.C. Bain Mucosal macrophages in intestinal homeostasis and inflammation J Innate Immun 3 2011 550 564
125. G. Mulcahy, S. O'Neill, S. Donnelly, and J.P. Dalton Helminths at mucosal barriers - interaction with the immune system Adv Drug Deliv Rev 56 2004 853 868
126. M.G. Neuman Immune dysfunction in inflammatory bowel disease Transl Res 149 2007 173 186
127. J.H. Niess, and H.C. Reinecker Dendritic cells: the commanders-in-chief of mucosal immune defenses Curr Opin Gastroenterol 22 2006 354 360
128. D.V. Ostanin, K.P. Pavlick, S. Bharwani, D. D'Souza, K.L. Furr, and C.M. Brown et al. T cell-induced inflammation of the small and large intestine in immunodeficient mice Am J Physiol Gastrointest Liver Physiol 290 2006 G109 G119
129. L. Pastorelli, C. De Salvo, J.R. Mercado, M. Vecchi, and T.T. Pizarro Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics Front Immunol 4 2013 280
130. J. Pedersen, M. Coskun, C. Soendergaard, M. Salem, and O.H. Nielsen Inflammatory pathways of importance for management of inflammatory bowel disease World J Gastroenterol 20 2014 64 77
131. S. Plevy The immunology of inflammatory bowel disease Gastroenterol Clin North Am 31 2002 77 92
132. D.K. Podolsky Inflammatory bowel disease N Engl J Med 347 2002 417 429
133. + T-cells induce or protect from chronic intestinal inflammation in C. B-17 Scid mice Int Immunol 5 1993 1461 1471
134. B. Pulendran, and D. Artis New paradigms in type 2 immunity Science 337 2012 431 435
135. J.E. Qualls, A.M. Kaplan, N. van Rooijen, and D.A. Cohen Suppression of experimental colitis by intestinal mononuclear phagocytes J Leukoc Biol 80 2006 802 815
136. S. Rautava, O. Ruuskanen, A. Ouwehand, S. Salminen, and E. Isolauri The hygiene hypothesis of atopic disease - an extended version J Pediatr Gastroenterol Nutr 38 2004 378 388
137. S. Read, and F. Powrie Induction of inflammatory bowel disease in immunodeficient mice by depletion of regulatory T cells J.E. Coligan, Current Protocols in Immunology 2001 (Unit 15 13)
138. C. Reardon, A. Sanchez, C.M. Hogaboam, and D.M. McKay Tapeworm infection reduces epithelial ion transport abnormalities in murine dextran sulfate sodium-induced colitis Infect Immun 69 2001 4417 4423
139. S. Rutella, and F. Locatelli Intestinal dendritic cells in the pathogenesis of inflammatory bowel disease World J Gastroenterol 17 2011 3761 3775
140. N.E. Ruyssers, B.Y. De Winter, J.G. De Man, A. Loukas, A.G. Herman, and P.A. Pelckmans et al. Worms and the treatment of inflammatory bowel disease: are molecules the answer? Clin Dev Immunol 2008 2008 567314
141. N.E. Ruyssers, B.Y. De Winter, J.G. De Man, A. Loukas, M.S. Pearson, and J.V. Weinstock et al. Therapeutic potential of helminth soluble proteins in TNBS-induced colitis in mice Inflamm Bowel Dis 15 2009 491 500
142. P. Salgame, G.S. Yap, and W.C. Gause Effect of helminth-induced immunity on infections with microbial pathogens Nat Immunol 14 2013 1118 1126
143. W.J. Sandborn, D.E. Elliott, J. Weinstock, R.W. Summers, A. Landry-Wheeler, and N. Silver et al. Randomised clinical trial: the safety and tolerability of Trichuris suis ova in patients with Crohn's disease Aliment Pharmacol Ther 38 2013 255 263
144. M. Scharl, and G. Rogler Inflammatory bowel disease: dysfunction of autophagy? Dig Dis 30 Suppl. 3 2012 12 19
145. C. Schnoeller, S. Rausch, S. Pillai, A. Avagyan, B.M. Wittig, and C. Loddenkemper et al. A helminth immunomodulator reduces allergic and inflammatory responses by induction of IL-10-producing macrophages J Immunol 180 2008 4265 4272
146. T. Setiawan, A. Metwali, A.M. Blum, M.N. Ince, J.F. Urban Jr., and D.E. Elliott et al. Heligmosomoides polygyrus promotes regulatory T-cell cytokine production in the murine normal distal intestine Infect Immun 75 2007 4655 4663
147. J.O. Shim Gut microbiota in inflammatory bowel disease Pediatr Gastroenterol Hepatol Nutr 16 2013 17 21
148. M.A. Silva Intestinal dendritic cells and epithelial barrier dysfunction in Crohn's disease Inflamm Bowel Dis 15 2009 436 453
149. M.C. Siracusa, J.J. Reece, J.F. Urban Jr., and A.L. Scott Dynamics of lung macrophage activation in response to helminth infection J Leukoc Biol 84 2008 1422 1433
150. K.A. Smith, K. Hochweller, G.J. Hammerling, L. Boon, A.S. MacDonald, and R.M. Maizels Chronic helminth infection promotes immune regulation in vivo through dominance of CD11cloCD103-dendritic cells J Immunol 186 2011 7098 7109
151. P. Smith, N.E. Mangan, C.M. Walsh, R.E. Fallon, A.N. McKenzie, and N. van Rooijen et al. Infection with a helminth parasite prevents experimental colitis via a macrophage-mediated mechanism J Immunol 178 2007 4557 4566
152. J.D. Soderholm, G. Olaison, K.H. Peterson, L.E. Franzen, T. Lindmark, and M. Wiren et al. Augmented increase in tight junction permeability by luminal stimuli in the non-inflamed ileum of Crohn's disease Gut 50 2002 307 313
153. R.A. Speight, and J.C. Mansfield Drug advances in inflammatory bowel disease Clin Med 13 2013 378 382
154. H. Spits, D. Artis, M. Colonna, A. Diefenbach, J.P. Di Santo, and G. Eberl et al. Innate lymphoid cells - a proposal for uniform nomenclature Nat Rev Immunol 13 2013 145 149
155. R.W. Summers, D.E. Elliott, K. Qadir, J.F. Urban, R. Thompson, and J.V. Weinstock Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease Am J Gastroenterol 98 2003 2034 2041
156. R.W. Summers, D.E. Elliott, J.F. Urban Jr., R. Thompson, and J.V. Weinstock Trichuris suis therapy in Crohn's disease Gut 54 2005 87 90
157. R.W. Summers, D.E. Elliott, J.F. Urban Jr., R.A. Thompson, and J.V. Weinstock Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial Gastroenterology 128 2005 825 832
158. R.W. Summers, D.E. Elliott, and J.V. Weinstock Is there a role for helminths in the therapy of inflammatory bowel disease? Nat Clin Pract Gastroenterol Hepatol 2 2005 62 63
159. T.L. Sutton, A. Zhao, K.B. Madden, J.E. Elfrey, B.A. Tuft, and C.A. Sullivan et al. Anti-inflammatory mechanisms of enteric Heligmosomoides polygyrus infection against trinitrobenzene sulfonic acid-induced colitis in a murine model Infect Immun 76 2008 4772 4782
160. + natural killer cells in the intestinal mucosa of patients with Crohn's disease Gastroenterology 139 2010 882 892 (892 e881-883)
161. M.D. Taylor, N. van der Werf, and R.M. Maizels T cells in helminth infection: the regulators and the regulated Trends Immunol 33 2012 181 189
162. A.H. van den Biggelaar, L.C. Rodrigues, R. van Ree, J.S. van der Zee, Y.C. Hoeksma-Kruize, and J.H. Souverijn et al. Long-term treatment of intestinal helminths increases mite skin-test reactivity in Gabonese schoolchildren J Infect Dis 189 2004 892 900
163. A.H. van den Biggelaar, R. van Ree, L.C. Rodrigues, B. Lell, A.M. Deelder, and P.G. Kremsner et al. Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10 Lancet 356 2000 1723 1727
164. E. Vivier, D.H. Raulet, A. Moretta, M.A. Caligiuri, L. Zitvogel, and L.L. Lanier et al. Innate or adaptive immunity? The example of natural killer cells Science 331 2011 44 49
165. S.T. Walk, A.M. Blum, S.A. Ewing, J.V. Weinstock, and V.B. Young Alteration of the murine gut microbiota during infection with the parasitic helminth Heligmosomoides polygyrus Inflamm Bowel Dis 16 2010 1841 1849
166. K.L. Wallace, L.B. Zheng, Y. Kanazawa, and D.Q. Shih Immunopathology of inflammatory bowel disease World J Gastroenterol 20 2014 6 21
167. A. Wang, M. Fernando, G. Leung, V. Phan, D. Smyth, and D.M. McKay Exacerbation of oxazolone colitis by infection with the helminth Hymenolepis diminuta: involvement of IL-5 and eosinophils Am J Pathol 177 2010 2850 2859
168. J.V. Weinstock Autoimmunity: the worm returns Nature 491 2012 183 185
169. J.V. Weinstock, and D.E. Elliott Translatability of helminth therapy in inflammatory bowel diseases Int J Parasitol 43 2013 245 251
170. J.V. Weinstck, R.W. Summers, and D.E. Ellitt Role of helminths in regulatyng mucosal inflammation Springer Semin Immunopathol 27 2005 2490271
171. R.A. Whelan, S. Hartmann, and S. Rausch Nematode modulation of inflammatory bowel disease Protoplasma 249 2012 871 886
172. -/- mice results from IL-13Ralpha2-mediated attenuation of IL-13 activity Gastroenterology 140 2011 254 264
173. S. Wirtz, C. Neufert, B. Weigmann, and M.F. Neurath Chemically induced mouse models of intestinal inflammation Nat Protoc 2 2007 541 546
174. S. Wirtz, and M.F. Neurath Animal models of intestinal inflammation: new insights into the molecular pathogenesis and immunotherapy of inflammatory bowel disease Int J Colorectal Dis 15 2000 144 160
175. S. Wirtz, and M.F. Neurath Mouse models of inflammatory bowel disease Adv Drug Deliv Rev 59 2007 1073 1083
176. M.J. Wolff, M.J. Broadhurst, and P. Loke Helminthic therapy: improving mucosal barrier function Trends Parasitol 28 2012 187 194
177. M. Wordemann, R.J. Diaz, L.M. Heredia, A.M. Collado Madurga, A. Ruiz Espinosa, and R.C. Prado et al. Association of atopy, asthma, allergic rhinoconjunctivitis, atopic dermatitis and intestinal helminth infections in Cuban children Trop Med Int Health 13 2008 180 186
178. R.J. Xavier, and D.K. Podolsky Unravelling the pathogenesis of inflammatory bowel disease Nature 448 2007 427 434
179. C.M. Xia, Y. Zhao, L. Jiang, J. Jiang, and S.C. Zhang Schistosoma japonicum ova maintains epithelial barrier function during experimental colitis World J Gastroenterol 17 2011 4810 4816
180. P.K. Yadav, C. Chen, and Z. Liu Potential role of NK cells in the pathogenesis of inflammatory bowel disease J Biomed Biotechnol 2011 2011 348530
181. M. Yazdanbakhsh, and S. Wahyuni The role of helminth infections in
182. + T cells Eur J Immunol 41 2011 2709 2718
183. P. Zaccone, O. Burton, N. Miller, F.M. Jones, D.W. Dunne, and A. Cooke Schistosoma mansoni egg antigens induce Treg that participate in diabetes prevention in NOD mice Eur J Immunol 39 2009 1098 1107
184. Z. Zhang, D.J. Hinrichs, H. Lu, H. Chen, W. Zhong, and J.K. Kolls After interleukin-12p40, are interleukin-23 and interleukin-17 the next therapeutic targets for inflammatory bowel disease? Int Immunopharmacol 7 2007 409 416
185. Y. Zhao, S. Zhang, L. Jiang, J. Jiang, and H. Liu Preventive effects of Schistosoma japonicum ova on trinitrobenzenesulfonic acid-induced colitis and bacterial translocation in mice J Gastroenterol Hepatol 24 2009 1775 1780